APDN Forms Subsidiary, LineaRx, to Develop DNA for Biotherapeutics
September 18th, 2018
All Categories
APDN in the News
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
Press Release
Uncategorized
Vaccines
Category: Press Release
APDN Executes New 2 Year Contract with the U.S. Defense Logistics Agency
September 11th, 2018
Applied DNA Announces $1.65 Million Private Placement of Secured Convertible Notes
September 4th, 2018
APDN Presenting Linear DNA for Gene Therapy at Boston Immuno-Oncology Summit
August 27th, 2018
Applied DNA Reports FY’18 Q3 Results
August 13th, 2018
Applied DNA Schedules Fiscal 2018 Third Quarter Financial Results Conference Call for Monday, August 13, 2018 at 4:30 PM ET
August 6th, 2018
Everledger to Build CertainT Blockchain Platform for High-end Markets
July 31st, 2018
Majority of US Consumers Concerned About Inauthentic Products
July 26th, 2018
APDN, TheraCann to Introduce Cannabis Tagging System at NCIA Summit & Expo
July 24th, 2018
